CHINA PHARMA HOLDINGS, INC. Increase (Decrease) in Other Accounts Payable and Accrued Liabilities
CHINA PHARMA HOLDINGS, INC. (CPHI) reported Increase (Decrease) in Other Accounts Payable and Accrued Liabilities of $176.95 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities · last filed 2026-08-14
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2026-06-30 was $191.21K, a 5.94% increase year-over-year.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2026-03-31 was -$14.26K.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2025-06-30 was $180.49K.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2025-03-31 was -$78.81K.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in other accounts payable and accrued liabilities for fiscal 2020 was -$111.16K.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in other accounts payable and accrued liabilities for fiscal 2019 was -$1.16M, a 285.36% decline from fiscal 2018.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in other accounts payable and accrued liabilities for fiscal 2018 was $625.13K.
| Period end | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $191.21K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $176.95K 10-Q · filed 2026-08-14 | ||
| 2026-03-31 | -$14.26K 10-Q · filed 2026-05-15 | |||
| 2025-06-30 | $180.49K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $101.68K 10-Q · filed 2026-08-14 | ||
| 2025-03-31 | -$78.81K 10-Q · filed 2026-05-15 | |||
| 2020-12-31 | -$1.50K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | -$226.63K derived: sum of 2 quarters · filed 2022-03-30 | -$337.37K derived: sum of 3 quarters · filed 2022-03-30 | -$111.16K 10-K · filed 2022-03-30 |
| 2020-09-30 | -$225.13K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$335.87K derived: sum of 2 quarters · filed 2021-11-12 | -$109.66K 10-Q · filed 2021-11-12 | -$495.13K derived: sum of 4 quarters · filed 2021-11-12 |
| 2020-06-30 | -$110.74K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $115.47K 10-Q · filed 2021-08-13 | -$270.00K derived: sum of 3 quarters · filed 2021-08-13 | -$261.63K derived: sum of 4 quarters · filed 2021-08-13 |
| 2020-03-31 | $226.21K 10-Q · filed 2021-05-14 | -$159.26K derived: sum of 2 quarters · filed 2021-05-14 | -$150.90K derived: sum of 3 quarters · filed 2021-05-14 | -$605.54K derived: sum of 4 quarters · filed 2021-05-14 |
| 2019-12-31 | -$385.46K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-26 | -$377.10K derived: sum of 2 quarters · filed 2021-03-26 | -$831.75K derived: sum of 3 quarters · filed 2021-03-26 | -$1.16M 10-K · filed 2021-03-26 |
| 2019-09-30 | $8.36K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | -$446.28K derived: sum of 2 quarters · filed 2020-11-13 | -$773.26K 10-Q · filed 2020-11-13 | |
| 2019-06-30 | -$454.64K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | -$781.63K 10-Q · filed 2020-08-13 | ||
| 2019-03-31 | -$326.98K 10-Q · filed 2020-05-14 | |||
| 2018-12-31 | $625.13K 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |